The third ongoing vaccine, Bharat Biotech’s Covaxin, which is being developed in collaboration with the Indian Council for Medical Research (ICMR), is simultaneously undergoing Phase 3 human trials at 22 sites in India with around 26,000 volunteers. . According to a senior company official, it will be at least 60 …
Read More »The SEC will meet today to authorize the emergency use of COVID vaccines
